Eqis Capital Management, Inc. Uni Qure N.V. Transaction History

Eqis Capital Management, Inc.

$1.17 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $65,973 - $81,390	-3,528 Reduced 25.13%	10,510 $211,000
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $11,778 - $17,758	-650 Reduced 4.43%	14,038 $318,000
Q3 2022 Oct 24, 2022	BUY	$16.98 - $25.54 $5,178 - $7,789	305 Added 2.12%	14,688 $275,000
Q2 2022 Aug 08, 2022	SELL	$13.15 - $20.45 $483,065 - $751,230	-36,735 Reduced 71.86%	14,383 $268,000
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $56,735 - $83,893	3,902 Added 8.26%	51,118 $924,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $154,512 - $274,900	-7,634 Reduced 13.92%	47,216 $979,000
Q3 2021 Nov 12, 2021	SELL	$26.01 - $38.22 $80,917 - $118,902	-3,111 Reduced 5.37%	54,850 $1.76 Million
Q2 2021 Aug 12, 2021	BUY	$29.97 - $37.17 $329,220 - $408,312	10,985 Added 23.38%	57,961 $1.79 Million
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $83,567 - $120,121	2,858 Added 6.48%	46,976 $1.58 Million
Q4 2020 Feb 11, 2021	SELL	$35.35 - $50.67 $116,195 - $166,552	-3,287 Reduced 6.93%	44,118 $1.59 Million
Q3 2020 Nov 10, 2020	SELL	$35.98 - $47.66 $104,126 - $137,928	-2,894 Reduced 5.75%	47,405 $1.75 Million
Q2 2020 Aug 10, 2020	SELL	$45.06 - $67.74 $261,302 - $392,824	-5,799 Reduced 10.34%	50,299 $2.27 Million
Q1 2020 May 12, 2020	BUY	$40.01 - $73.97 $485,401 - $897,404	12,132 Added 27.59%	56,098 $3.39 Million
Q4 2019 Jan 24, 2020	BUY	$37.13 - $74.62 $459,855 - $924,168	12,385 Added 39.22%	43,966 $3.15 Million
Q3 2019 Nov 05, 2019	BUY	$39.36 - $76.8 $175,348 - $342,144	4,455 Added 16.42%	31,581 $1.24 Million
Q2 2019 Jul 18, 2019	BUY	$52.76 - $82.19 $178,276 - $277,720	3,379 Added 14.23%	27,126 $2.12 Million
Q1 2019 Apr 18, 2019	SELL	$27.39 - $68.41 $1.5 Million - $3.74 Million	-54,725 Reduced 69.74%	23,747 $1.42 Million
Q4 2018 Jan 25, 2019	SELL	$22.8 - $33.93 $33,721 - $50,182	-1,479 Reduced 1.85%	78,472 $2.26 Million
Q3 2018 Oct 17, 2018	BUY	$29.75 - $43.08 $15,351 - $22,229	516 Added 0.65%	79,951 $3.44 Million
Q2 2018 Jul 27, 2018	BUY	$21.96 - $39.94 $1.74 Million - $3.17 Million	79,435 New	79,435 $3 Million

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account